Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (20 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Product revenue
33
56
63
62
44
36
43
Service and other revenue
7
9
13
14
18
13
14
Total revenue
40
65
75
76
62
49
57
Cost of product revenue
26
40
48
43
33
29
32
Cost of service and other revenue
5
7
10
9
9
7
9
Total cost of goods sold
31
47
58
52
42
36
41
Gross Profit
9
18
18
25
19
13
17
Research and development
4
3
5
5
7
7
6
Selling and marketing
11
13
14
14
12
12
11
General and administrative
5
5
6
7
8
6
7
Total operating expenses
20
22
25
26
27
25
23
Loss from operations
11
-4
-7
-2
-8
-12
-6
Interest expense
0
0
0
0
0
0
0
Other expense, net
0
0
0
0
0
0
0
Loss before income taxes
-11
-4
0
-2
-8
-13
-6
Income tax expense
0
0
0
0
0
0
0
Net loss
-11
-4
-7
-2
-8
-13
-6
Translation loss on subsidiaries denominated in foreign currencies
1
0
0
0
0
0
0
Change in unrealized gain (loss) on investments in marketable securities
0
0
0
0
0
0
0
Net loss
-11
-4
-7
-2
-8
-13
-6
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 4, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (25 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
15
10
14
12
15
12
Short-term investments in marketable securities
n/a
0
0
0
0
0
0
Restricted cash
n/a
0
0
0
1
0
0
Accounts receivable, net of allowance for doubtful accounts of $70 and $212 at December 31, 2015 and December 31, 2014, respectively
n/a
15
11
18
9
11
9
Inventories, net
n/a
6
9
11
12
7
6
Prepaid expenses and other
n/a
1
0
1
1
1
1
Total current assets
n/a
37
32
43
35
34
28
Property and equipment, net
n/a
2
3
2
3
2
2
Deposits and other
n/a
0
0
0
0
0
0
Total assets
n/a
40
35
46
38
36
31
Liabilities and owners' equity
Accounts payable
n/a
6 6022000
5 4757000
4 4036000
3 2993000
4 4044000
3 2852000
Accrued expenses
n/a
7 7068000
5 5351000
5 4948000
6 5583000
4 4134000
4 4494000
Deferred revenue
n/a
2 2492000
2 2366000
5 4568000
3 2749000
3 2771000
4 3576000
Revolving line of credit
n/a
3 2535000
6 5535000
6 5535000
6 5535000
6 5535000
6 5535000
Total current liabilities
n/a
18 18117000
18 18009000
19 19087000
17 16860000
16 16484000
16 16457000
Long-term liabilities
n/a
1 579000
1 726000
1 713000
1 741000
1 821000
1 583000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock - $0.001 par value; 2,000 shares authorized
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock - $0.001 par value; 40,000 shares authorized; 23,171 and 23,162 issued and 23,109 and 23,094 outstanding at December 31, 2015 and 2014, respectively
n/a
0 80000
0 16000
0 19000
0 19000
0 23000
0 23000
Treasury stock
n/a
0 -103000
0 -115000
0 -144000
0 -215000
0 -231000
0 -240000
Additional paid-in capital
n/a
275 274807000
277 277087000
289 288619000
291 290964000
303 302667000
304 304094000
Accumulated deficit
n/a
-254 -253801000
-261 -260895000
-263 -262817000
-271 -271168000
-284 -283995000
-290 -290454000
Other accumulated comprehensive income
n/a
0 -161000
0 199000
0 322000
1 706000
0 329000
0 132000
Total stockholders' equity
n/a
21 20822000
16 16292000
26 25999000
20 20306000
19 18793000
14 13555000
Total liabilities and stockholders' equity
n/a
40 39518000
35 35027000
46 45799000
38 37907000
36 36098000
31 30595000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Mar 4, 2013 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net loss
-11
-4
-7
-2
-8
-13
-6
Depreciation expense
2
2
1
1
1
1
1
Accretion of premium / discount on investments
0
0
0
0
0
0
0
Change to allowance for doubtful accounts
0
0
0
0
0
0
0
Loss on disposal of fixed assets
0
0
0
0
0
0
0
Impairment on fixed assets
0
0
0
0
0
0
0
Stock-based compensation
1
1
2
1
2
1
1
Restricted cash
0
0
0
0
-1
0
0
Accounts receivable
-2
-3
4
-7
9
-2
3
Inventories
0
0
-3
-2
-2
5
0
Prepaid expenses and other assets
0
0
0
0
0
0
0
Accounts payable
3
1
-1
-1
-1
1
-1
Accrued expenses
0
2
-2
0
1
-1
0
Deferred revenue
0
1
0
2
-2
0
1
Long term liabilities
0
0
0
0
0
0
0
Net cash used in operating activities
-7
0
-7
-6
-1
-7
-2
Purchases of marketable securities
0
0
0
0
0
0
0
Sales/maturities of marketable securities
1
0
0
0
0
0
0
Purchases of property and equipment
-1
-1
-2
-1
-1
0
-1
Increase in restricted cash
0
0
0
0
0
0
0
Proceeds from sale of fixed assets
0
0
0
0
0
0
0
Net cash used in investing activities
0
-1
-2
-1
-1
0
-1
Proceeds from public offering of common stock, net of issuance cost
0
0
0
0
0
10
0
Proceeds from private placement of common stock
3
10
0
10
0
0
0
Issuance costs of private placement
0
-1
0
0
0
0
0
Purchases of treasury stock
0
0
0
0
0
0
0
Proceeds from draw on revolving line of credit
1
1
3
2
0
0
0
Payments on revolving line of credit
0
-1
0
-2
0
0
0
Proceeds from employee stock option exercises
0
0
1
1
1
0
0
Issuance costs, shelf registration
0
0
0
0
0
0
0
Taxes paid related to the net share settlement of equity awards
0
0
0
0
0
0
0
Net cash (used in) provided by financing activities
3
9
3
10
1
11
0
Effects of exchange rates on cash
1
0
0
0
0
0
0
Change in cash and cash equivalents
-3
8
-5
3
-1
3
-3
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 4, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo